Use of FDA’s Sentinel System to Quantify Seizure Risk Immediately Following New Ranolazine Exposure
Sign Up to like & getrecommendations! Published in 2019 at "Drug Safety"
DOI: 10.1007/s40264-019-00798-2
Abstract: IntroductionNeurological complications including seizures have been reported with ranolazine. We sought to quantify the risk of seizure-related hospitalizations or emergency department events following ranolazine exposure in the Sentinel System (2006–2015).Study Design and SettingEligibility criteria were… read more here.
Keywords: seizure risk; seizure; risk; ranolazine exposure ... See more keywords